EUVIMEDEUVIMED entdecken
Crossref

CD21lo B-cell subsets are recruited to the central nervous system in acute neuromyelitis optica

Ryusei Nishigori iD, Mio Hamatani, Hiroyuki Yoshitomi, Kimitoshi Kimura iD, Masaki Takata, Shinji Ashida, Chihiro Fujii, Hirofumi Ochi, Ryosuke Takahashi iD, Takayuki Kondo, Hideki Ueno

Brain · 2025

DOI: 10.1093/brain/awaf086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2025. Verfasst von Ryusei Nishigori und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto 6068507, Japan. Hauptthemen laut MEDLINE: Neuromyelitis Optica, B-Lymphocyte Subsets, Central Nervous System, Receptors, Complement 3d. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Takeda Science Foundation, Chugai Pharmaceutical Co., Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuromyelitis optica (NMO) is an acute inflammatory demyelinating disease of the CNS. The presence of astrocyte-targeted AQP4-immunoglobulin G (IgG) in peripheral blood is a major factor in its diagnosis. Previous studies show that AQP4-IgG contributes directly to CNS inflammation and that B cells play a central pathogenic role in NMO. However, where and how the B-cell response is altered remains controversial. In this study, we used high-parameter flow cytometry to carry out a comprehensive analysis of the immune cell populations in the CSF samples obtained from first-episode acute-phase NMO patients, compared with those from patients with acute-phase multiple sclerosis and other neurological diseases. Among 10 immune cell populations defined in the analysis, the frequency only of B cells and antibody-secreting cells (ASC) was higher in the CSF of acute-phase NMO compared with other neurological diseases. Detailed assessments of B-cell and ASC subsets in the CSF revealed differences in the dominant subsets between NMO and multiple sclerosis. In NMO, a series of CD21lo B-cell subsets, including ‘activated’ naïve B, double-negative and switched memory subsets, considered as ASC precursors, were dominant. A majority of these CD21lo B-cell subsets expressed CD69 and CXCR3, suggesting their CNS residency. An increase of CD21lo B-cell subsets was also observed in the CSF of treatment-refractory NMO patients. Furthermore, two B-helper T-cell subsets, T peripheral helper type 1 and T follicular helper type 1 cells, both highly expressing CD69 and CXCR3, were enriched in the CSF of NMO patients, suggesting their interactions with ASC precursors in the CNS. In vitro culture experiments using blood samples from patients with NMO showed that CD21lo B cells included AQP4-IgG-producing cells and displayed a high propensity to differentiate into ASCs. We also found that CD21lo B-cell subsets in NMO upregulated the expression of C5a receptors, and C5a signals promoted their differentiation into ASCs. ASCs derived from CD21lo B cells expressed high levels of CXCR3 and CD138. The increase in CD21lo B-cell subsets was significantly correlated with the annual relapse rate. Collectively, our study strongly suggests that the mechanism to promote the generation of CD21lo B cells, probably via the extrafollicular pathway, becomes activated during the acute phase of NMO and that the generated CD21lo B-cell subsets contribute to the pathogenesis. Targeting CD21lo B-cell subsets might be useful for the development of novel therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuromyelitis OpticaB-Lymphocyte SubsetsCentral Nervous SystemReceptors, Complement 3dHumansFemaleMaleAdultMiddle AgedYoung AdultFlow CytometryMultiple Sclerosis

Stichwörter der Autor:innen

atypical memory B cellsfollicular helper T cellsperipheral helper T cellsplasmablastsspectral flow cytometrytissue resident memory cells

Substanzen

Receptors, Complement 3d

Autor:innen und Institutionen

  • Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto 6068507, Japan.
  • Department of Immunology, Kyoto University Graduate School of Medicine, Kyoto 6068501, Japan.
  • Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto 6068501, Japan.
  • Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 6028566, Japan.
  • Department of Neurology, Kansai Medical University Medical Center, Moriguchi 5708507, Japan.
  • Department of Intractable Disease and Aging Science, Ehime University Graduate School of Medicine, Ehime 7910295, Japan.

ORCID-Profile: Ryusei Nishigori, Kimitoshi Kimura, Ryosuke Takahashi

Förderung

  • Takeda Science Foundation
  • Chugai Pharmaceutical Co., Ltd

Zitieren

APA

Nishigori, R., Hamatani, M., Yoshitomi, H., Kimura, K., Takata, M., Ashida, S., Fujii, C., Ochi, H., Takahashi, R., Kondo, T., & Ueno, H. (2025). CD21lo B-cell subsets are recruited to the central nervous system in acute neuromyelitis optica. Brain. https://doi.org/10.1093/brain/awaf086

Vancouver

Nishigori R, Hamatani M, Yoshitomi H, Kimura K, Takata M, Ashida S, et al. CD21lo B-cell subsets are recruited to the central nervous system in acute neuromyelitis optica. Brain. 2025. doi:10.1093/brain/awaf086

BibTeX
@article{Nishigori2025,
  author = {Nishigori, Ryusei and Hamatani, Mio and Yoshitomi, Hiroyuki and Kimura, Kimitoshi and Takata, Masaki and Ashida, Shinji and Fujii, Chihiro and Ochi, Hirofumi and Takahashi, Ryosuke and Kondo, Takayuki and Ueno, Hideki},
  title = {CD21lo B-cell subsets are recruited to the central nervous system in acute neuromyelitis optica},
  journal = {Brain},
  year = {2025},
  doi = {10.1093/brain/awaf086}
}
Kostenlos starten →